New Innovaccer research report applies machine learning algorithms to 55+ factors to deliver one of the most accurate views ever for social determinants of healthUS clinicians are at a critical juncture, newly responsible for both the quality and value of care and expected to have a deeper understanding of their patients’ risk factors. The health impacts of the environment in which patients live affect their health and these health impacts need to be documented and studied properly.According to
Read More
Stanford, Proteus Releases 10 Guiding Principles for Ethics in Digital Health
The need for increased protection and better management of personal health data has never been greater than in healthcare today and is without a doubt one of the most important issues of our time. With consumers are using a flurry of tools/applications – it is important that organizations are transparent about how they use consumer data, following ethical principles that everyone understands.That’s why, Proteus worked closely with Michael Keller of the Stanford Libraries and more than
Read More
Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly
The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
ICON Acquires Precision Medicine for Oncology Company MolecularMD
ICON, a global provider of drug development solutions and services has acquired MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology. The acquisition of MolecularMD’s extensive scientific and clinical biomarker experience expands the ICON’s capabilities in molecular diagnostic testing and also adds expanded testing platforms, including next-generation sequencing and immunohistochemistry, to ICON’s
Read More
Study: VR-AI Therapy Cuts Night Flashes in Half for Cancer Patients
A new clinical study from VRHealth cites that breast cancer patients reduced hot flashes and night sweats by 50% using VR-AI therapy coaching environment. In addition, study participants reported significant improvements in their sleep quality and fewer disruptions to their daily lives following a three-week experiment with the VR solution. VRHealth is a digital health company focused on helping clinicians better manage their patients' care via specialized virtual reality (VR) technology
Read More
CVS-Aetna Merger Impact : Consumers Open to Receiving Primary Care at CVS Clinics
The CVS-Aetna merger has the potential to create an integrated model for consumer healthcare that could transform the consumer experience; however, are consumers embracing the prospect of receiving care in a CVS retail pharmacy setting? According to new research from J.D. Power, forty-five percent of consumers said they would probably or definitely would use primary care services in a CVS retail pharmacy setting. CVS-Aetna Merger Consumer Impact Survey BackgroundJ.D. Power's December 2018 pulse
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
Ochsner Health and Pfizer to Develop Innovative Models for Clinical Trials
Ochsner Health System and Pfizer Inc, today announced it has entered into a multi-year strategic alliance to develop innovative models for clinical trials that will explore ways to enhance the clinical trial experience and ease participation in clinical research for both patients and healthcare professionals. Through its innovation lab, innovationOchsner (iO), in partnership with Oschner Research, the alliance aims to create faster, improved access and connectivity to clinical trials for
Read More
10 Major Themes Driving The Future of Blockchain in Healthcare
Partners in Digital Health, communications company publishing the peer review journals Blockchain in Healthcare Today (BHTY) has announced their first annual BHTY Top 10 Blockchain Predictions for Healthcare 2019. With over 20,000 downloads, 18 citations, and readership in over 65 countries worldwide, Blockchain Healthcare Today (BHTY) is the preeminent open-access international peer-review journal for strategic thought leaders, new-era practitioners, and future society stakeholders engaged in
Read More
Glooko Launches Integration with Novo Nordisk Insulin Pen
Today, Glooko announced the launch of their integration with the Novo Nordisk connected insulin pen on our diasend® platform and the release of their Annual Diabetes Report. With diasend, doctors were able to see and advise patients based on recorded insulin dose data from connected Novo Nordisk pens without having to invest additional time. Now, to raise the bar for patient convenience even further, Glooko is launching the ability to also upload pen data remotely – straight from any near field
Read More
